The Right to Try Act of 2017 just scored a major win. The bill will give terminally ill patients the ability to seek out experimental treatments and drugs in the US rather than having to travel to abroad.
One of the largest health insurance companies in the nation, Anthem, is reportedly buying Aspire Health which would expand its services for members outside of the insurance and into the community.
After the announcement of a major healthcare partnership with JP Morgan Chase and Berkshire Hathaway that sent shockwaves, Amazon’s new health insurance initiative for employees is off to a rough start.
Novartis and Amgen, two pharmaceutical companies, have just announced the FDA approval of their one of a kind drug. Aimovig, the migraine drug, is already making waves as the first of its kind to prevent migraines rather than manage them.
The US has a shortage of doctors and nurses, and reports are indicating that an even larger shortage may be looming. See what a shortage of healthcare professionals can mean for you, and what can be done to solve the problem before it's too late.